Elanco Animal Health (NYSE: ELAN)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-08 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.350 | 0.360 | 0.0100 | ||||
REV | 1.220B | 1.225B | 5.000M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Elanco Animal Health (NYSE: ELAN) through any online brokerage.
Other companies in Elanco Animal Health’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Roivant Sciences (NASDAQ:ROIV).
The latest price target for Elanco Animal Health (NYSE: ELAN) was reported by Goldman Sachs on Thursday, May 19, 2022. The analyst firm set a price target for 32.00 expecting ELAN to rise to within 12 months (a possible 37.52% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Elanco Animal Health (NYSE: ELAN) is $23.27 last updated May 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Elanco Animal Health.
Elanco Animal Health’s Q2 earnings are confirmed for Monday, August 8, 2022.
There is no upcoming split for Elanco Animal Health.
Elanco Animal Health is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.